Search

everythinglearnresearchcommunity

for

Search:↓

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Spironolactone does not increase the risk of breast cancer recurrence.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Patients with chronic kidney disease often have various skin problems that affect their quality of life, but early treatment can help.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Erlotinib can cause persistent excessive hair growth.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Pancreatic cancer had a very low survival rate and was hard to treat effectively.

Higher cholesterol levels increase aggressive prostate cancer risk.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Understanding breast cancer requires considering both medical advancements and social influences.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

PRP hair treatment is generally safe but may cause minor pain, bleeding, redness, and scalp tightness, and isn't suitable for everyone.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.